HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Liquid Dosing Accuracy Four-Times Better With Oral Syringes – Study

This article was originally published in The Pink Sheet

Executive Summary

Pediatric OTC and Rx dosage errors reach 43% for parents using a dosing cup but 16.7% with a 0.2 mL oral syringe, according to researchers who say recommending oral syringes over cups, particularly for small doses, should be part of a comprehensive pediatric labeling and dosing strategy.

You may also be interested in...



CHPA Offers Accuracy Standard For Stock Photos Of Dosing, Administering OTC Liquids To Children

Trade group's Educational Foundation, working with CDC's PROTECT Initiative, is providing more than 80 royalty-free stock photos, available to download at no cost, which will help report and show practices for dosing and administering OTC liquids to children.

US Recalls: Incorrect Dosing Cups In Robitussin, Dimetapp; Lidocaine Patch GMP Records Lost

GSK recalls two lots of Children's Robitussin DM and one lot of Children's Dimetapp found to include incorrect dosing cups. Chinese firm Bingbing Pharmaceutical recalls 456,760 lidocaine patches due to the loss of product manufacturing records and product samples.

Potential Pediatric Acetaminophen Label Changes Resurface In Tylenol Class Action Settlement

Settlement could be another milestone in the contentious history of labeling for OTC acetaminophen single-ingredient products generally, and for infant’s and children’s products specifically. Plaintiffs alleged they were misled by J&J to pay more for Infant's Tylenol even though its formulation is the same as Children's Tylenol.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS123108

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel